Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Perricone

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Drug Development Research|November 11, 2014
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patientsEleonora Ballanti, Paola Conigliaro, Maria Sole Chimenti, et al.
Clinical Rheumatology|August 19, 2021
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvementMaria Sole Chimenti, Paola Conigliaro, Francesco Caso, et al.
Internal and Emergency Medicine|September 5, 2013
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian expertsMarco Cicardi, Paolo Bellis, Giuliano Bertazzoni, et al.
Clinical and Experimental Rheumatology|June 8, 2019
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approachMaria Sole Chimenti, Paola Conigliaro, Paola Triggianese, et al.
Expert Opinion on Biological Therapy|August 1, 2018
Serum thymosin alpha 1 levels in normal and pathological conditionsFrancesca Pica, Roberta Gaziano, Ida Antonia Casalinuovo, et al.
Drugs & Aging|June 29, 2019
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and ManagementFrancesco Caso, Marco Tasso, Maria Sole Chimenti, et al.
Clinical Rheumatology|January 6, 2018
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric studyMaria Sole Chimenti, Augusta Ortolan, Mariagrazia Lorenzin, et al.
Frontiers in Immunology|November 16, 2018
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative StressMaria Sole Chimenti, Flavia Sunzini, Laura Fiorucci, et al.
Expert Opinion on Pharmacotherapy|September 12, 2017
Small molecule therapy for managing moderate to severe psoriatic arthritisLuisa Costa, Antonio Del Puente, Rosario Peluso, et al.
Arthritis and Rheumatism|September 2, 2006
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implicationsPaola Cipriani, Anna Franca Milia, Vasiliki Liakouli, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Drug Development Research|November 11, 2014
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patientsEleonora Ballanti, Paola Conigliaro, Maria Sole Chimenti, et al.
Clinical Rheumatology|August 19, 2021
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvementMaria Sole Chimenti, Paola Conigliaro, Francesco Caso, et al.
Internal and Emergency Medicine|September 5, 2013
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian expertsMarco Cicardi, Paolo Bellis, Giuliano Bertazzoni, et al.
Clinical and Experimental Rheumatology|June 8, 2019
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approachMaria Sole Chimenti, Paola Conigliaro, Paola Triggianese, et al.
Expert Opinion on Biological Therapy|August 1, 2018
Serum thymosin alpha 1 levels in normal and pathological conditionsFrancesca Pica, Roberta Gaziano, Ida Antonia Casalinuovo, et al.
Drugs & Aging|June 29, 2019
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and ManagementFrancesco Caso, Marco Tasso, Maria Sole Chimenti, et al.
Clinical Rheumatology|January 6, 2018
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric studyMaria Sole Chimenti, Augusta Ortolan, Mariagrazia Lorenzin, et al.
Frontiers in Immunology|November 16, 2018
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative StressMaria Sole Chimenti, Flavia Sunzini, Laura Fiorucci, et al.
Expert Opinion on Pharmacotherapy|September 12, 2017
Small molecule therapy for managing moderate to severe psoriatic arthritisLuisa Costa, Antonio Del Puente, Rosario Peluso, et al.
Arthritis and Rheumatism|September 2, 2006
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implicationsPaola Cipriani, Anna Franca Milia, Vasiliki Liakouli, et al.
Pageof 14